Immunotherapy News and Research

Latest Immunotherapy News and Research

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Cleveland Clinic researchers have demonstrated for the first time that lowering blood cholesterol levels could enhance the success of a specific type of T-cell immunotherapy in fighting cancer.

16 May 2018

Tufts University, BioLabs announce the opening of new biotech facility for life sciences entrepreneurs

Tufts University and BioLabs today announced the opening of Tufts Launchpad | BioLabs, a full-service biotech facility supporting high-potential, early-stage life sciences startup ventures in the Boston area.

16 May 2018

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Turnstone Biologics today announced it has received U.S. Food and Drug Administration clearance of its Investigational New Drug Application for MG1-HPV for the treatment of patients with human papillomavirus positive solid tumors.

16 May 2018

Study finds distinct exhausted T cells that could have implications for fighting different diseases

The battle between the human immune system and long-term, persisting infections and other chronic diseases such as cancer results in a prolonged stalemate

16 May 2018

Genetic fixer-uppers could aid in predicting prognosis of patients with bladder cancer

Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers.

15 May 2018

Researchers test new cancer research model that may reduce cost and speed up studies

A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical companies is being tested by research experts at The University of Texas MD Anderson Cancer Center.

15 May 2018

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Multiple myeloma is the second most common type of blood cancer in the United States, impacting more than 25,000 people each year and disproportionatly affecting African-American men.

15 May 2018

Researchers discover unique mechanism that regulates tumor growth in lung cancer

Lung cancer is the third most common type of cancer in Germany and the disease affects both men and women. However, immunotherapies are successful in only 20 percent of cases.

14 May 2018

Queen's University researchers receive MRC award to develop new treatment for pancreatic cancer

Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.

11 May 2018

Researchers manipulate bacterial species in the gut using diet

Scientists from Stanford University School of Medicine have shown that by manipulating diet in a mouse model, it is possible to favor the engraftment of a specific bacterial strain over others.

10 May 2018

New case study shows CAR T therapy as viable option for AML patients

Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune cells to fight cancer.

9 May 2018

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.

8 May 2018

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer treatment decisions, today announced the presentation of data supporting clinical use of the DecisionDx®-Melanoma test to inform sentinel lymph node biopsy (SLNB) recommendations.

7 May 2018

Ocular oncologists link immunotherapy with potentially vision-robbing side effect

New immunotherapy treatments offer a remarkable chance for survival for patients with advanced melanoma and hard-to-treat cancers of the bladder, kidney and lung.

4 May 2018

Cancer Center at BIDMC announces launch of new Immunotherapy Institute

The Cancer Center at Beth Israel Deaconess Medical Center today announced the launch of a new clinical and research institute that will build on BIDMC's long history of leadership in immunotherapy and cell therapeutics.

3 May 2018

Study uncovers unconventional killer T cells capable of combating viral infections

Research led by the University of Birmingham has identified a novel unconventional type of immune cell capable of fighting viral infections.

2 May 2018

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia don't respond to chimeric antigen receptor T cell therapy, and the answer is tied to how primed patients' immune systems are before the therapy is administered.

30 Apr 2018

Immunotherapy News and Research

Latest Immunotherapy News and Research

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Tufts University, BioLabs announce the opening of new biotech facility for life sciences entrepreneurs

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Study finds distinct exhausted T cells that could have implications for fighting different diseases

Genetic fixer-uppers could aid in predicting prognosis of patients with bladder cancer

Researchers test new cancer research model that may reduce cost and speed up studies

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Researchers discover unique mechanism that regulates tumor growth in lung cancer

Queen's University researchers receive MRC award to develop new treatment for pancreatic cancer

Researchers manipulate bacterial species in the gut using diet

New case study shows CAR T therapy as viable option for AML patients

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Ocular oncologists link immunotherapy with potentially vision-robbing side effect

Cancer Center at BIDMC announces launch of new Immunotherapy Institute

Study uncovers unconventional killer T cells capable of combating viral infections

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Hollings Cancer Center immunologist inducted into Association of American Physicians

Best reads of the week from Brianna Labuskes

Researchers recommend anti-cancer immunotherapies for treatment of thyroid cancer

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Immunotherapy News and Research

Latest Immunotherapy News and Research

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in